Crofelemer can potentially extend lives of MVID patients – infants and children who face the lethal natural history of the disease Parenteral support reduction of up to 37% is groundbreaking; No ...

Major depressive disorder (MDD) is characterized by a lowered mood and loss of interest, contributing not only to ...

The FDA said it has received postmarketing reports of neutralizing antibodies to ADAMTS13, including one death, in patients ...

The regulator has received reports that a group of patients treated with Adzynma had neutralizing antibodies against the ...

Discover the key borderline personality disorder symptoms in females, how they differ from men, and effective ways to treat BPD symptoms.

For patients recovering from opioid use disorder, particularly from drugs like fentanyl or heroin, the days immediately ...

Internal records reveal that for years Penn State’s clinical cancer research was mired in deep-rooted and potentially dangerous problems. Then the people tasked with fixing it were dismissed.

Takeda Pharmaceuticals' drug Adzynma is being investigated by the U.S. Food and Drug Administration due to a death following treatment. The FDA said Friday it has received reports of neutralizing ...

At Beyond Addiction symposium at UAlbany, Dr. Joshua Lynch detailed how the MATTERS app connects New Yorkers to telemedicine ...

Parkinson’s Disease Causes, Symptoms, and Treatment Parkinson’s disease (PD) is one of the fastest-growing neurological ...

Vanda advances with strong Fanapt growth, late-stage catalysts, GLP-1 potential, higher investment and solid balance sheet ...